FDA Adverse Event Injury Summary report: N

ACCOLADE EL DR

MDR report key: 13137219 · Received January 1, 2022

Report

Report Number
2124215-2021-32250
Event Type
Injury
Date Received
January 1, 2022
Date of Event
October 12, 2021
Report Date
December 28, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
LWP
UDI-DI
00802526559242
PMA / PMN Number
N970003/S167
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE H6 FIELDS HAVE BEEN UPDATED BASED ON NEW INFORMATION RECEIVED. SHOULD FURTHER INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 0

THE H6 FIELDS HAVE BEEN UPDATED BASED ON NEW INFORMATION RECEIVED. SHOULD FURTHER INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 0

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THIS DEVICE WAS THOROUGHLY INSPECTED AND ANALYZED. A HIGH CURRENT DRAIN WAS DETECTED, BUT THE BATTERY STILL SUPPORTED FULL DEVICE FUNCTION. DETAILED ANALYSIS CONFIRMED THE IDENTIFIED HIGH CURRENT DRAIN WAS A RESULT OF COMPROMISED CAPACITORS. THIS RESULTED IN THE OBSERVED PREMATURE BATTERY DEPLETION. IT WAS DETERMINED THAT THE CAPACITORS WERE COMPROMISED DUE TO THE PRESENCE OF EXCESS HYDROGEN IN THE DEVICE CASE. BOSTON SCIENTIFIC ISSUED A FIELD SAFETY NOTICE REGARDING A SUBSET OF DEVICES IN THE ACCOLADE PACEMAKER FAMILY THAT HAVE A POTENTIAL OF EXHIBITING THIS BEHAVIOR. THIS PARTICULAR DEVICE IS INCLUDED IN THE HYDROGEN INDUCED PREMATURE DEPLETION ADVISORY POPULATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE CONCERNS OF PREMATURE BATTERY DEPLETION (PBD) FOR THIS PACEMAKER AS THE BATTERY LONGEVITY PROJECTION HAD DEPLETED MORE THAN EXPECTED SINCE THE LAST CHECKUP. BASED ON THE AVAILABLE DATA BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) ESTIMATED A SAFE REPLACEMENT INTERVAL OF 90 DAYS AND DISCUSSED OPTIONS. THE DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. INFORMATION WAS RECEIVED APPROXIMATELY TWO MONTHS AFTER THE INITIAL REPORT AND DATA ANALYSIS BY TS CONFIRMED THAT THE BATTERY CONSUMPTION HAD BEEN INCREASING. DEVICE REPLACEMENT WAS RECOMMENDED WITHIN 90 DAYS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE CONCERNS OF PREMATURE BATTERY DEPLETION (PBD) FOR THIS PACEMAKER AS THE BATTERY LONGEVITY PROJECTION HAD DEPLETED MORE THAN EXPECTED SINCE THE LAST CHECKUP. BASED ON THE AVAILABLE DATA BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) ESTIMATED A SAFE REPLACEMENT INTERVAL OF 90 DAYS AND DISCUSSED OPTIONS. THE DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. INFORMATION WAS RECEIVED APPROXIMATELY TWO MONTHS AFTER THE INITIAL REPORT AND DATA ANALYSIS BY TS CONFIRMED THAT THE BATTERY CONSUMPTION HAD BEEN INCREASING. DEVICE REPLACEMENT WAS RECOMMENDED WITHIN 90 DAYS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE CONCERNS OF PREMATURE BATTERY DEPLETION (PBD) FOR THIS PACEMAKER AS THE BATTERY LONGEVITY PROJECTION HAD DEPLETED MORE THAN EXPECTED SINCE THE LAST CHECKUP. BASED ON THE AVAILABLE DATA BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) ESTIMATED A SAFE REPLACEMENT INTERVAL OF 90 DAYS AND DISCUSSED OPTIONS. THE DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. INFORMATION WAS RECEIVED APPROXIMATELY TWO MONTHS AFTER THE INITIAL REPORT AND DATA ANALYSIS BY TS CONFIRMED THAT THE BATTERY CONSUMPTION HAD BEEN INCREASING. DEVICE REPLACEMENT WAS RECOMMENDED WITHIN 90 DAYS. FURTHER INFORMATION WAS RECEIVED THAT THIS PACEMAKER WAS EXPLANTED AND SUCCESSFULLY REPLACED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE CONCERNS OF PREMATURE BATTERY DEPLETION (PBD) FOR THIS PACEMAKER AS THE BATTERY LONGEVITY PROJECTION HAD DEPLETED MORE THAN EXPECTED SINCE THE LAST CHECKUP. BASED ON THE AVAILABLE DATA BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) ESTIMATED A SAFE REPLACEMENT INTERVAL OF 90 DAYS AND DISCUSSED OPTIONS. THE DEVICE REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. INFORMATION WAS RECEIVED APPROXIMATELY TWO MONTHS AFTER THE INITIAL REPORT AND DATA ANALYSIS BY TS CONFIRMED THAT THE BATTERY CONSUMPTION HAD BEEN INCREASING. DEVICE REPLACEMENT WAS RECOMMENDED WITHIN 90 DAYS. FURTHER INFORMATION WAS RECEIVED THAT THIS PACEMAKER WAS EXPLANTED AND SUCCESSFULLY REPLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1436204 ACCOLADE EL DR PACEMAKER LWP BOSTON SCIENTIFIC CORPORATION L321 707153 00802526559242

Patients

Seq Age Sex Outcome Treatment
1 58 YR Male Required Intervention| H